Pierre Laurin

453 total citations
21 papers, 222 citations indexed

About

Pierre Laurin is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Pierre Laurin has authored 21 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in Pierre Laurin's work include Liver Disease Diagnosis and Treatment (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Liver physiology and pathology (2 papers). Pierre Laurin is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Liver physiology and pathology (2 papers). Pierre Laurin collaborates with scholars based in Canada, United States and Serbia. Pierre Laurin's co-authors include Lyne Gagnon, John Moran, Joseph M. Parker, Gary Albert, Brigitte Grouix, Paul Hernandez, Christopher J. Ryerson, Éric Turcotte, H. Manganas and Martin Kolb and has published in prestigious journals such as Circulation, Blood and Journal of Hepatology.

In The Last Decade

Pierre Laurin

21 papers receiving 218 citations

Peers

Pierre Laurin

PRM

PHYSI

SURGE

EDM

Taihei Yanagida Japan

Kana Ide Japan

Feiming Ye China

Ana Persson Sweden

Kelly Kernan United States

José Román Escudero Spain

Alexandru R. Constantinescu United States

Mi Yeon Kang South Korea

Ling Dong China

Laura Dowsett United Kingdom

Taihei Yanagida Japan

Pierre Laurin

45 ×0.5

PRM

91 ×1.7

43 ×1.2

PHYSI

20 ×0.8

SURGE

25 ×1.3

EDM

Citations per year, relative to Pierre Laurin Pierre Laurin (= 1×) peers Taihei Yanagida

Countries citing papers authored by Pierre Laurin

Since Specialization

Citations

This map shows the geographic impact of Pierre Laurin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Laurin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Laurin more than expected).

Fields of papers citing papers by Pierre Laurin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Laurin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Laurin. The network helps show where Pierre Laurin may publish in the future.

Co-authorship network of co-authors of Pierre Laurin

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Laurin. A scholar is included among the top collaborators of Pierre Laurin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Laurin. Pierre Laurin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dupuis, Jocelyn, Pierre Laurin, Jean‐Claude Tardif, et al.. (2022). Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 12 indexed citations

Gagnon, Lyne, Martin Leduc, Jean-François Thibodeau, et al.. (2019). FO008FATTY ACID RECEPTORS GPR40/GPR84: TWO PROMISING TARGETS IN KIDNEY FIBROSIS. Nephrology Dialysis Transplantation. 34(Supplement_1). 1 indexed citations

Gagnon, Lyne, Jean-François Thibodeau, Chet E. Holterman, et al.. (2019). SP345ACTIVATION OF THE FREE-FATTY ACID RECEPTOR GPR40 IMPROVES ANEMIA IN MOUSE MODELS OF KIDNEY DISEASE VIA A NOVEL EPO-INDEPENDENT MECHANISM OF ACTION. Nephrology Dialysis Transplantation. 34(Supplement_1). 1 indexed citations

Nguyen, Quang T., Mohamed Jalloul Nsaibia, Martin G. Sirois, et al.. (2019). PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure. Cardiovascular Research. 116(1). 171–182. 20 indexed citations

Li, Yan, Sungjin Chung, Zhilian Li, et al.. (2018). Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control. JCI Insight. 3(10). 22 indexed citations

Khalil, Nasreen, H. Manganas, Christopher J. Ryerson, et al.. (2018). Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis. European Respiratory Journal. 53(3). 1800663–1800663. 84 indexed citations

Grouix, Brigitte, Martin Leduc, Jean-Christophe Simard, et al.. (2018). PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway. Journal of Pharmacology and Experimental Therapeutics. 367(1). 71–81. 22 indexed citations

Zacharie, Boulos, Jean‐Simon Duceppe, Lyne Gagnon, et al.. (2018). Design and Synthesis of New 1,3,5‐Trisubstituted Triazines for the Treatment of Cancer and Inflammation. ChemistryOpen. 7(9). 737–749. 10 indexed citations

Grouix, Brigitte, et al.. (2017). PBI-4050 reduces liver damage and fibrosis in a high-fat diet mouse model of obesity and metabolic syndrome. Journal of Hepatology. 66(1). S165–S165. 1 indexed citations

10.

Gagnon, Lyne, Brigitte Grouix, Pierre Laurin, & Martin Leduc. (2017). PBI-4050 reduces expression of fibrosis biomarkers in the BioMAP SAEMyoF primary human small airway epithelial cells and lung myofibroblasts system. PA1005–PA1005. 1 indexed citations

11.

Laurin, Pierre, et al.. (2016). Abstract 19469: PBI-4050 Reduces Cardiovascular Biomarkers in Type II Diabetic Patients With Metabolic Syndrome. Circulation. 2 indexed citations

12.

Gagnon, Lyne, et al.. (2016). SP251TREATMENT EFFICACY OF PBI-4050, AN ORALLY ACTIVE ANTIFIBROTIC AGENT, CAN BE MONITORED BY FOLLOWING URINARY BIOMARKERS IN 5/6-NEPHRECTOMIZED RATS. Nephrology Dialysis Transplantation. 31(suppl_1). i171–i171. 1 indexed citations

13.

Grouix, Brigitte, et al.. (2016). PBI-4050 Decreases Hepatic Stellate Cell Activation and Ameliorates Fibrosis in Carbon Tetrachloride (CCL4)- Induced Hepatic Fibrosis Model. Journal of Hepatology. 64(2). S707–S707. 1 indexed citations

14.

Gagnon, Lyne, Martin Leduc, Brigitte Grouix, et al.. (2015). SP102ORAL TREATMENT WITH PBI-4050 REDUCES KIDNEY FIBROSIS. Nephrology Dialysis Transplantation. 30(suppl_3). iii411–iii412. 2 indexed citations

15.

Gagnon, Lyne, Ming‐Zhi Zhang, Brigitte Grouix, et al.. (2015). FP445PBI-4050 PROTECTS AGAINST RENAL AND PANCREATIC FIBROSIS IN TYPE II DIABETES. Nephrology Dialysis Transplantation. 30(suppl_3). iii220–iii220. 1 indexed citations

16.

Gagnon, Lyne, Lilianne Geerts, Jean‐Simon Duceppe, et al.. (2014). P72 ORAL TREATMENT WITH PBI-4050, A NOVEL FIRST-IN-CLASS ANTI-FIBROTIC COMPOUND, REDUCES HEPATIC FIBROSIS AND HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 60(1). S90–S90. 3 indexed citations

17.

Leduc, Martin, et al.. (2013). PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model. 42. 4746. 1 indexed citations

18.

Gagnon, Lyne, J. Barabé, Christopher Penney, et al.. (2007). Oral Treatment with PBI-1402 Increases Hemoglobin Level and Red Blood Cell Count: A Novel Approach to Treating Chemotherapy-Induced Anemia.. Blood. 110(11). 2211–2211. 2 indexed citations

19.

Gagnon, Lyne, J. Barabé, Brigitte Grouix, et al.. (2006). PBI-1402: A New Candidate for the Treatment of Anemia.. Blood. 108(11). 4223–4223. 1 indexed citations

20.

Ducharme, J.R., et al.. (1979). Further Studies on the Relationship of Adrenal and Gonadal Steroids in Pubertal Development in Female Rats. Hormone Research. 10(2-3). 130–142. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact